Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-02

FDA Approved: NITROFURANTOIN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original ANDA for nitrofurantoin, a generic antibiotic. The approval covers its use for urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

ORIG AP for NITROFURANTOIN (NITROFURANTOIN)